Denali Therapeutics

DNLI

Insider trades and stock quote 2024-2026

All insider trades at Denali Therapeutics

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/11/2026 Sell Schuth, Alexander O. COFO and Secretary $25.1 $71,625
1/6/2026 Sell Watts, Ryan J. President and CEO $16.5 $580,767
1/6/2026 Sell Schuth, Alexander O. COFO and Secretary $16.5 $284,097
8/13/2025 Sell Ho, Carole Chief Medical Officer $14.6 $11,800
8/12/2025 Sell Ho, Carole Chief Medical Officer $13.6 $39,884
8/12/2025 Sell Schuth, Alexander O. COFO and Secretary $13.6 $39,884
7/9/2025 Sell Watts, Ryan J. President and CEO $15.0 $7,429,230
1/7/2025 Sell Krognes, Steve E. Director $20.8 $69,485
1/7/2025 Sell Watts, Ryan J. President and CEO $20.8 $159,197
1/7/2025 Sell Schuth, Alexander O. COFO and Secretary $20.8 $60,495
1/7/2025 Sell Ho, Carole Chief Medical Officer $20.8 $60,495
1/6/2025 Sell Watts, Ryan J. President and CEO $20.2 $591,759
1/6/2025 Sell Schuth, Alexander O. COFO and Secretary $20.2 $247,796
1/6/2025 Sell Ho, Carole Chief Medical Officer $20.2 $247,796
1/2/2025 Sell Sato, Vicki L. Director $20.9 $64,403
12/31/2024 Sell Krognes, Steve E. Director $20.2 $607,500
11/11/2024 Sell Schenkein, David P. Director $32.5 $1,932,665
11/7/2024 Sell Sato, Vicki L. Director $30.0 $30,600
11/7/2024 Sell Schuth, Alexander O. COFO and Secretary $30.6 $465,286
11/1/2024 Sell Sato, Vicki L. Director $27.1 $83,376
10/18/2024 Sell Watts, Ryan J. President and CEO $27.7 $1,107,600
9/30/2024 Sell Krognes, Steve E. Director $29.0 $870,900
9/13/2024 Sell Sato, Vicki L. Director $30.0 $30,600
9/3/2024 Sell Sato, Vicki L. Director $25.2 $77,007
8/21/2024 Sell Ho, Carole Chief Medical Officer $24.7 $491,571
8/21/2024 Sell Schuth, Alexander O. COFO and Secretary $24.8 $63,115
8/20/2024 Sell Ho, Carole Chief Medical Officer $23.8 $58,357
8/20/2024 Sell Schuth, Alexander O. COFO and Secretary $23.7 $137,287
8/20/2024 Sell Krognes, Steve E. Director $23.8 $41,085
8/20/2024 Sell Watts, Ryan J. President and CEO $23.8 $53,765
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)